Tongshu Gene

About:

Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine.

Website: https://www.tongshugene.net/

Top Investors: Broad Vision Funds, Everest Venture Capital, Oceanpine Capital, GL Capital, Jiangsu Jiandao Venture Capital

Description:

Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine. The company provides gene testing services and develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis to provide clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, and risk prediction and early detection.

Total Funding Amount:

600M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Changzhou, Zhejiang, China

Founded Date:

2016-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-10-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai